MedTech Dive - Latest News

Judge rules J&J unit must pay $442M in antitrust case

A federal judge awarded triple damages after a jury found Biosense Webster withheld support to hospitals that bought reprocessed catheters.

Jun 9, 2025 - 15:40
 0
Judge rules J&J unit must pay $442M in antitrust case

A federal judge awarded triple damages after a jury found Biosense Webster withheld support to hospitals that bought reprocessed catheters.

Read More

Tags:

Previous Article

#226 TCT 3Sixty 2025: Insights from the UK home of additive manufacturing

Next Article

Empire Metals develops TiO2 product with 99.25% purity

Related Posts

Merit buys hemostatic device maker Biolife for $120M

Merit buys hemostatic device maker Biolife for $120M

May 21, 2025  0

Cost cuts, production shifts: How medtech firms are managing tariffs

Cost cuts, production shifts: How medtech firms are man...

May 22, 2025  0

J&J may take a softer tariff hit after US-China pause, CFO says

J&J may take a softer tariff hit after US-China pause, ...

Jun 4, 2025  0